Improving combination trials for multiple sclerosis.
Trojano
Maria
M
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004359:Drug Therapy, Combination / Q000379:methods; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D018696:Neuroprotective Agents / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D018696:Neuroprotective Agents; D016899:Interferon-beta; D008775:Methylprednisolone; D000068556:Interferon beta-1a